Benefits and risks associated with thrombolysis for pulmonary embolism--reply

JAMA. 2014 Oct 15;312(15):1589-90. doi: 10.1001/jama.2014.10789.

Authors

Saurav Chatterjee¹, Jay Giri²

Affiliations

¹ Division of Cardiology, St Luke's-Roosevelt Hospital, New York, New York.
² Cardiovascular Medicine Division, University of Pennsylvania Perelman School of Medicine, Philadelphia.

PMID: 25321916
DOI: 10.1001/jama.2014.10789

No abstract available

Publication types

Letter
Comment

MeSH terms

Anticoagulants / adverse effects*
Fibrinolytic Agents / adverse effects*
Humans
Intracranial Hemorrhages / chemically induced*
Pulmonary Embolism / drug therapy*
Thrombolytic Therapy*

Substances

Anticoagulants
Fibrinolytic Agents